Epix to form technology advisory board

By AuntMinnie.com staff writers

August 14, 2008 -- MRI contrast developer Epix Pharmaceuticals has formed a technology advisory board to help the company with its in silico modeling drug discovery platform, the Lexington, MA-based company said.

Board members include the following:

  • Charles Brooks, Ph.D., a Warner-Lambert/Parke-Davis professor of chemistry and a professor of biophysics in the Department of Chemistry at the University of Michigan
  • Johan Aqvist, Ph.D., a professor of theoretical chemistry in the Department of Cell and Molecular Biology at Uppsala University, Sweden
  • Gabriele Cruciani, Ph.D., a professor of organic chemistry and cheminformatics in the Laboratory for Chemometrics and Cheminformatics at the University of Perugia, Italy

Epix's Q2 results show boosted revenues, August 7, 2008

Epix secures equity financing, August 5, 2008

Epix CEO resigns, July 28, 2008

Epix wins South Korean approval of Vasovist, July 10, 2008

Epix resubmits Vasovist NDA, July 1, 2008

Copyright © 2008 AuntMinnie.com


To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking